Search Page

1

Cite

Share

Tumor necrosis factor inhibitors and uveitis: comment on the article by Lim et al.

Sfikakis PP, Markomichelakis N. Sfikakis PP, et al. Among authors: markomichelakis n. Arthritis Rheum. 2008 May;58(5):1554-5; author reply 1556-7. doi: 10.1002/art.23442. Arthritis Rheum. 2008. PMID: 18438832 No abstract available.

Cite

Share

2

Cite

Share

Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.

Sfikakis PP, Markomichelakis N, Theodossiadis GP, Grigoropoulos V, Katsilambros N, Theodossiadis PG. Sfikakis PP, et al. Among authors: markomichelakis n. Diabetes Care. 2005 Feb;28(2):445-7. doi: 10.2337/diacare.28.2.445. Diabetes Care. 2005. PMID: 15677814 Clinical Trial. No abstract available.

Cite

Share

3

Cite

Share

Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.

Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H. Sfikakis PP, et al. Among authors: markomichelakis n. Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2. Rheumatology (Oxford). 2007. PMID: 17403712 Review. No abstract available.

Cite

Share

4

Cite

Share

Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.

Markomichelakis N, Delicha E, Masselos S, Sfikakis PP. Markomichelakis N, et al. Am J Ophthalmol. 2012 Sep;154(3):534-541.e1. doi: 10.1016/j.ajo.2012.03.035. Epub 2012 Jul 11. Am J Ophthalmol. 2012. PMID: 22789563

Cite

Share

5

Cite

Share

Brief Report: Drug-Free Long-Term Remission in Severe Behçet's Disease Following Withdrawal of Successful Anti-Tumor Necrosis Factor Treatment.

Sfikakis PP, Arida A, Panopoulos S, Fragiadaki K, Pentazos G, Laskari K, Tektonidou M, Markomichelakis N. Sfikakis PP, et al. Among authors: markomichelakis n. Arthritis Rheumatol. 2017 Dec;69(12):2380-2385. doi: 10.1002/art.40235. Epub 2017 Nov 8. Arthritis Rheumatol. 2017. PMID: 28834393 Free article.

Cite

Share

6

Cite

Share

Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography.

Markomichelakis NN, Halkiadakis I, Pantelia E, Peponis V, Patelis A, Theodossiadis P, Theodossiadis G. Markomichelakis NN, et al. Ophthalmology. 2004 May;111(5):946-53. doi: 10.1016/j.ophtha.2003.08.037. Ophthalmology. 2004. PMID: 15121373

Cite

Share

7

Cite

Share

Regression of neovascular age-related macular degeneration following infliximab therapy.

Markomichelakis NN, Theodossiadis PG, Sfikakis PP. Markomichelakis NN, et al. Am J Ophthalmol. 2005 Mar;139(3):537-40. doi: 10.1016/j.ajo.2004.09.058. Am J Ophthalmol. 2005. PMID: 15767068

Cite

Share

8

Cite

Share

Macular hole closure after peribulbar steroid injection.

Halkiadakis I, Pantelia E, Giannakopoulos N, Koutsandrea C, Markomichelakis NN. Halkiadakis I, et al. Among authors: markomichelakis nn. Am J Ophthalmol. 2003 Dec;136(6):1165-7. doi: 10.1016/s0002-9394(03)00668-8. Am J Ophthalmol. 2003. PMID: 14644235

Cite

Share

9

Cite

Share

Retinal detachment due to a macular hole in a patient with Behcet disease treated with vitrectomy and silicone oil tamponade.

Georgalas I, Markomichelakis N, Ladas I. Georgalas I, et al. Among authors: markomichelakis n. Eur J Ophthalmol. 2008 Nov-Dec;18(6):1023-4. doi: 10.1177/112067210801800630. Eur J Ophthalmol. 2008. PMID: 18988182

Cite

Share

10

Cite

Share

Evaluation of single-dose azithromycin versus standard azithromycin/doxycycline treatment and clinical assessment of regression course in patients with adult inclusion conjunctivitis.

Malamos P, Georgalas I, Rallis K, Andrianopoulos K, Georgopoulos G, Theodossiadis P, Vergados I, Markomichelakis NN. Malamos P, et al. Among authors: markomichelakis nn. Curr Eye Res. 2013 Dec;38(12):1198-206. doi: 10.3109/02713683.2013.822893. Epub 2013 Sep 18. Curr Eye Res. 2013. PMID: 24047438 Clinical Trial.

Cite

Share